John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:

  • Relationship between time-varying achieved HbA1cand risk of coronary artery disease events among common haptoglobin phenotype groups with type 2 diabetes: the ADVANCE study

    BMJ Open Diabetes Research & Care Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:

  • Hypertension and orthostatic hypertension in 85-year-olds and associations with mortality and cognitive decline in a longitudinal cohort study

    Scientific Reports Date published:

  • Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study

    Stroke Date published:

  • Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE

    BMC Medicine Date published:

  • Orthostatic Hypotension and Cognitive Function in Individuals 85 Years of Age: A Longitudinal Cohort Study in Sweden

    Aging and disease Date published:

  • Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial

    Diabetes Care Date published:

  • Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke

    Neurology Date published:

  • Influence of renal function on blood pressure control and outcome in thrombolyzed patients after acute ischemic stroke: post-hoc analysis of the ENCHANTED trial

    Frontiers in Endocrinology Date published:

  • Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial

    Journal of Hypertension Date published:

  • Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study

    Journal of the American Heart Association Date published:

  • Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study

    Diabetes, Obesity and Metabolism Date published:

  • Randomised controlled decentralised feasibility trial of a fixed low-dose combination antihypertensive drug strategy to attenuate cognitive decline in high-risk adults

    BMJ Open Date published:

  • Prescription and dispensing duration of medicines for hypertension and other chronic conditions: a review of international policies and evidence to inform the Australian setting

    Hypertension Research Date published:

  • Predictors of Early versus Delayed Neurological Deterioration after Thrombolysis for Ischemic Stroke

    Cerebrovascular Diseases Date published: